Accenture Reports Q3 Results, Lowers Full-Year Revenue Guidance, Boosts Capital Return
Summary
Accenture announced Q3 fiscal 2026 results, reporting solid revenue and EPS growth, but lowered its full-year revenue guidance while slightly raising its EPS outlook and increasing capital return plans.
Key Events
-
Solid Q3 Financial Performance
Accenture reported third-quarter fiscal 2026 revenues of $18.7 billion, up 6% in U.S. dollars (3% in local currency), and diluted earnings per share (EPS) of $3.80, a 9% increase year-over-year. Operating margin expanded by 20 basis points to 17.0%.
-
Full-Year Revenue Guidance Lowered
The company now expects full-year fiscal 2026 revenue growth to be 3% to 4% in local currency, a reduction from the previous outlook of 3% to 5%. Excluding its U.S. federal business, the revised outlook is 4% to 5% (previously 4% to 6%).
-
Full-Year EPS Guidance Slightly Raised
Accenture updated its full-year GAAP diluted EPS guidance to a range of $13.38 to $13.50 (previously $13.25 to $13.50), representing a 10% to 11% increase over fiscal 2025. Adjusted EPS guidance also saw a slight increase at the lower end.
-
Increased Capital Return
The company increased its full-year capital return expectation to at least $9.5 billion, up from the previous forecast of at least $9.3 billion. During Q3, Accenture repurchased 6.0 million shares for $1.2 billion.
Analysis
Accenture reported solid third-quarter results with revenue and EPS growth, alongside strong free cash flow and increased share repurchases. However, the company lowered its full-year revenue growth outlook, which is a key concern for investors, especially as the stock is currently trading below its 52-week low. While the lower end of EPS guidance was slightly raised and capital return plans were increased, the reduced revenue forecast suggests ongoing challenges in demand or market conditions.
At the time of this filing, ACN was trading at $147.86 on NYSE in the Trade & Services sector, with a market capitalization of approximately $95.8B. The 52-week trading range was $155.82 to $315.95. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.